Search Results - "Lluch, Josep Ramon Germà"
-
1
Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer
Published in Breast cancer research and treatment (01-06-2008)“…Introduction Changes in breast cancer cell biology following hormonal treatment have been claimed as promising predictor markers of clinical benefit even…”
Get full text
Journal Article -
2
Molecular bases of platinum-resistance in testicular cancer
Published in Archivos españoles de urología (01-06-2013)“…Cisplatin has been the cornerstone of germ cell testicular tumors therapy since its introduction more tan 30 years ago, and a basic part of the schemes given…”
Get full text
Journal Article -
3
A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours
Published in European journal of cancer (1990) (01-08-2006)“…The aim of this study was to determine the safety and feasibility profile of paclitaxel (PTX) and docetaxel (DTX) in combination and the pharmacokinetic and…”
Get full text
Journal Article -
4
Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma
Published in Melanoma research (01-08-2006)“…Temozolomide is a novel oral alkylating agent, active against metastatic melanoma. Combinations of chemotherapy and biological response modifiers have been…”
Get full text
Journal Article -
5
Importancia de la valoración geriátrica en las personas mayores con cáncer
Published in Revista española de geriatría y gerontología (2010)Get full text
Journal Article -
6
Importance of geriatric assessment in the elderly with cancer
Published in Revista española de geriatría y gerontología (01-05-2010)Get full text
Journal Article -
7
Evaluation of clinical research studies in a comprehensive cancer center
Published in Medicina clínica (21-02-2004)“…The number of clinical trials in cancer patients has experienced an important growth during last years. However, it is difficult to find data showing this…”
Get more information
Journal Article -
8
A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors
Published in Journal of liposome research (01-12-2009)“…As a dose-finding phase I study of a new liposomal formulation of doxorubicin (LipD), patients (n = 39; median age: 60 years; range, 41-75; median ECOG…”
Get full text
Journal Article